Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 0.67 ▲ 0.02 (2.69%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Advaxis Inc | ADXS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.013 | -1.96% | 0.65 | 0.72 | 0.632 | 0.6913 | 0.663 | 00:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.585 | 0.7383 | 0.1533 | 20.76% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,140 | 3,899,490 | $ 0.6628729 | $ 2,584,866 | 8,389,005 | 0.181 - 10.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:29:29 | formt | 11,078 | $ 0.6675 | USD |
Advaxis Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 16.06M | 24.71M | $ -66.52M | -19.74 | -8.61 | 20.30M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 9.00 | 17.80% |
Advaxis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADXS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.64 | 0.989 | 0.55 | 0.7308152 | 15,218,423 | 0.01 | 1.56% |
| 1 Month | 0.3865 | 0.989 | 0.3531 | 0.5780882 | 11,337,541 | 0.2635 | 68.18% |
| 3 Months | 0.29 | 0.989 | 0.202 | 0.4336598 | 8,786,645 | 0.36 | 124.14% |
| 6 Months | 2.58 | 2.72 | 0.202 | 0.4408286 | 4,784,655 | -1.93 | -74.81% |
| 1 Year | 0.37 | 10.80 | 0.181 | 0.6214299 | 3,011,694 | 0.28 | 75.68% |
| 3 Years | 8.86 | 10.80 | 0.181 | 1.71 | 1,508,481 | -8.21 | -92.66% |
| 5 Years | 3.85 | 30.13 | 0.181 | 5.50 | 1,358,112 | -3.20 | -83.12% |
Advaxis Description
| Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer. |
